| Literature DB >> 29178447 |
Marine Legendre1,2, Véronique Abadie3,4, Tania Attié-Bitach5,6, Nicole Philip7, Tiffany Busa7, Dominique Bonneau8, Estelle Colin8, Hélène Dollfus9, Didier Lacombe10, Annick Toutain11, Sophie Blesson11, Sophie Julia12, Dominique Martin-Coignard13, David Geneviève14, Bruno Leheup15, Sylvie Odent16, Pierre-Simon Jouk17, Sandra Mercier18, Laurence Faivre19, Catherine Vincent-Delorme20, Christine Francannet21, Sophie Naudion10, Michèle Mathieu-Dramard22, Marie-Ange Delrue10, Alice Goldenberg23, Delphine Héron24, Philippe Parent25, Renaud Touraine26, Valérie Layet27, Damien Sanlaville28, Chloé Quélin16, Sébastien Moutton10, Mélanie Fradin16, Aurélia Jacquette24, Sabine Sigaudy7, Lucile Pinson14, Pierre Sarda14, Anne-Marie Guerrot23, Massimiliano Rossi28, Alice Masurel-Paulet19, Salima El Chehadeh19, Xavier Piguel29, Montserrat Rodriguez-Ballesteros1, Stéphanie Ragot30,31, Stanislas Lyonnet5,6, Frédéric Bilan1,2, Brigitte Gilbert-Dussardier1,2.
Abstract
CHARGE syndrome (CS) is a genetic disorder whose first description included Coloboma, Heart disease, Atresia of choanae, Retarded growth and development, Genital hypoplasia, and Ear anomalies and deafness, most often caused by a genetic mutation in the CHD7 gene. Two features were then added: semicircular canal anomalies and arhinencephaly/olfactory bulb agenesis, with classification of typical, partial, or atypical forms on the basis of major and minor clinical criteria. The detection rate of a pathogenic variant in the CHD7 gene varies from 67% to 90%. To try to have an overview of this heterogenous clinical condition and specify a genotype-phenotype relation, we conducted a national study of phenotype and genotype in 119 patients with CS. Selected clinical diagnostic criteria were from Verloes (2005), updated by Blake & Prasad (). Besides obtaining a detailed clinical description, when possible, patients underwent a full ophthalmologic examination, audiometry, temporal bone CT scan, gonadotropin analysis, and olfactory-bulb MRI. All patients underwent CHD7 sequencing and MLPA analysis. We found a pathogenic CHD7 variant in 83% of typical CS cases and 58% of atypical cases. Pathogenic variants in the CHD7 gene were classified by the expected impact on the protein. In all, 90% of patients had a typical form of CS and 10% an atypical form. The most frequent features were deafness/semicircular canal hypoplasia (94%), pituitary defect/hypogonadism (89%), external ear anomalies (87%), square-shaped face (81%), and arhinencephaly/anosmia (80%). Coloboma (73%), heart defects (65%), and choanal atresia (43%) were less frequent.Entities:
Keywords: CHARGE syndrome; CHD7 gene; genotype; phenotype
Mesh:
Substances:
Year: 2017 PMID: 29178447 DOI: 10.1002/ajmg.c.31591
Source DB: PubMed Journal: Am J Med Genet C Semin Med Genet ISSN: 1552-4868 Impact factor: 3.908